Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, and COSMED srl, a worldwide leader in the design of metabolic systems for clinical and human performance applications, today announced an agreement to commercialize Q-NRG+, a...

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced it has been named a 2019 Top 10 Percent Inclusion Index Company, the highest-scoring category of Diversity Best Practices' (DBP) annual Inclusion Index.

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today issued this statement: We support the add-on payment that is included in the End-Stage Renal Disease (ESRD) Prospective Payment System proposed rule released by the Centers for...

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today the release of its 2018 Corporate Responsibility Report, which showcases the company's progress on key initiatives to drive more sustainable operations,...

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced receipt of a major research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF)'s "From Material to Innovation" program to...

Baxter International Inc. (NYSE: BAX), a global leader in acute care therapies, announced today that the peer-reviewed journal Blood Purification published a supplemental issue sponsored by Baxter that features real-world clinical experience with the...

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that representatives of the company will conduct a series of Fixed Income Investor Presentations on Thursday, May 9, 2019.

Baxter International Inc. (NYSE:BAX), a global leader in renal care, along with the National Association for the Advancement of Colored People (NAACP) and the Alliance for Home Dialysis, today announced that the Dialysis Health Imperative for Access,...